Repligen Corp (RGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN)

RGEN 142.18

+1.8%

Feb 6 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (162)	10/11/1999 12:29:00 PM
From: Cheryl Galt	Read Replies (2) of 395

Secretin was on the front page of Medscape on Friday (and through Sunday) -- Medscape Daily News, the In Focus column. -- report from the U of Chicago of a small 8-week study (20 children) -- Ferring's porcine secretin -- one infusion -- 2 CU/kg "double-blind, placebo-controlled, crossover study examining the effects of this hormone on 20 children with autistic disorder" "This sample is part of a larger, multisite study with a total planned sample size of 60 with the University of Utah and the University of California-Irvine. Preliminary data are reported in the interest of the many clinicians and parents interested in the potential efficacy of secretin in making a difficult treatment decision." ----------------------- I checked Biospace, quite a few Friday and weekend newspapers, PR Newswire daily biotech news, ... The item did not appear in any of them. Cheryl medscape.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next